Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Open-Label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer

NCT04729114 is registered in ClinicalTrials.gov with Astellas Pharma Global Development, Inc. as lead sponsor.

NCT NCT04729114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04729114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Open-Label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer
Lead sponsor
Astellas Pharma Global Development, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
June 14, 2021
Completion date
May 31, 2029
Enrollment
174 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration resistant prostate cancer, metastatic castration-sensitive prostate cancer, prostate cancer